Teva Pharmaceutical Industries reported $14.02B in Loan Capital for its fiscal quarter ending in March of 2026.





Loan Capital Change Date
Aspen Pharmacare ZAR 29.34B 1.93B Dec/2025
Cipla INR 3.82B 840.2M Mar/2026
Dr.Reddys Laboratories INR 12.2B 595M Mar/2026
Guangzhou Baiy CNY 4.86B 1.29B Mar/2026
Jiangsu Hengrui CNY 37.1M 6.2M Mar/2026
Kalbe Farma IDR 169.81B 37.21B Sep/2025
Richter Gedeon HUF 15.07B 75M Mar/2026
Sh Fosun Pharma CNY 15.95B 562.19M Mar/2026
Sun Pharmaceuticals INR 3.93B 309.9M Mar/2026
Teva Pharmaceutical Industries USD 14.02B 971M Mar/2026